Uses of Ecwin 7.5mg Tablet
Ecwin 7.5mg Tablet is used for the treatment or prevention of the following disease(s):
Arthritis, Reduces Pain, Swelling and Stiffness of the Joints
Side effects of Ecwin 7.5mg Tablet
The most common side effects of Ecwin 7.5mg Tablet are - Weakness,
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while taking Ecwin 7.5mg Tablet
Do not use Ecwin 7.5mg Tablet if you are allergic to - Meloxicam
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Ecwin 7.5mg Tablet.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
Dosage of Ecwin 7.5mg Tablet
Ecwin 7.5mg Tablet contains - Meloxicam
Meloxicam blocks cyclooxygenase (COX), the enzyme responsible for converting arachidonic acid into prostaglandin H2-the first step in the synthesis of prostaglandins, which are mediators of inflammation.
Overdose of Ecwin 7.5mg Tablet
The dosage of Ecwin 7.5mg Tablet depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Onset of Action of Ecwin 7.5mg Tablet
If you forget to take a dose of Ecwin 7.5mg Tablet, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Duration of Action of Ecwin 7.5mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
Interactions
Information will be added soon.